Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005-2017.
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
7
7
2023
pubmed:
6
7
2023
entrez:
6
7
2023
Statut:
ppublish
Résumé
Data regarding the dilated cardiomyopathy (DCM)-related mortality and relative time trends in the Italian population remain scant. We sought to assess the DCM mortality rates and relative trends among the Italian population between 2005 and 2017. Annual death rates by sex and 5-year age group were extracted from the WHO global mortality database. The age-standardized mortality rates, with relative 95% confidence intervals (95% CIs), also stratified by sex, were calculated using the direct method. Joinpoint regression analyses were used to identify periods with statistically distinct log linear trends in DCM-related death rates. To calculate nationwide annual trends in DCM-related mortality, we assessed the average annual percentage change (AAPC) and relative 95% CIs. In Italy, the DCM age-standardized annual mortality rate decreased from 4.99 (95% CI: 4.97-5.02) deaths per 100 000 to 2.51 (95% CI: 2.49-2.52) deaths per 100 000 population. Over the entire period, men had a higher DCM-related mortality rates than women. Moreover, the mortality rate increased with age, with a seemingly exponential distribution and showing a similar trend among men and women. Joinpoint regression analysis revealed a linear decrease in age-standardized DCM-related mortality from 2005 to 2017 [AAPC: -5.1% (95% CI: -5.9 to -4.3, P < 0.001)] in the entire Italian population. However, the decline was more pronounced among women [AAPC: -5.6 (95% CI: -6.4 to -4.8, P < 0.001)] compared with men [AAPC: -4.9 (95% CI: -5.8 to -4.1, P < 0.001)]. In Italy, the DCM-related mortality rates linearly declined from 2005 to 2017.
Identifiants
pubmed: 37409598
doi: 10.2459/JCM.0000000000001512
pii: 01244665-202308000-00007
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
530-536Informations de copyright
Copyright © 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.
Références
Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 2016; 67:2996–3010.
Weintraub RG, Semsarian C, Macdonald P, et al. Dilated cardiomyopathy. Lancet 2017; 390:400–414.
Schultheiss HP, Fairweather D, Caforio ALP, et al. Dilated cardiomyopathy. Nat Rev Dis Primers 2019; 5:32.
Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113:1807–1816.
Merlo M, Pivetta A, Pinamonti B, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail 2014; 16:317–324.
Merlo M, Cannatà A, Pio Loco C, et al. Contemporary survival trends and aetiological characterization in nonischaemic dilated cardiomyopathy. Eur J Heart Fail 2020; 22:1111–1121.
WHO Mortality database. Available at: https://www.who.int/data/data-collection-tools/who-mortality-database . [Accessed 24 September 2022].
WHO Mortality dabase methodology. Available at: https://www.who.int/news-room/questions-and-answers/item/whomortality-database [Accessed 24 September 2022].
Sundbøll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 2016; 6:e012832.
https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028 [Accessed 24 September 2022].
Agrinier N, Thilly N, Briancon S, et al. Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: results of the observational community-based EPICAL cohort study. Int J Cardiol 2017; 228:940–947.
Hunt SA, Baker DW, Chin MH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure); International Society for Heart and Lung Transplantation; Heart Failure Society of America. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104:2996–3007.
Cannatà A, Merlo M, Dal Ferro M, et al. Association of titin variations with late-onset dilated cardiomyopathy. JAMA Cardiol 2022; 7:371–377.
Manca P, Nuzzi V, Cannatà A, et al. The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child. Heart Fail Rev 2022; 27:1795–1805.
Sjöland H, Silverdal J, Bollano E, Pivodic A, Dahlström U, Fu M. Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003–2015. BMC Cardiovasc Disord 2021; 21:307.
Mitropoulou P, Georgiopoulos G, Figliozzi S, Klettas D, Nicoli F, Masci PG. Multi-modality imaging in dilated cardiomyopathy: with a focus on the role of cardiac magnetic resonance. Front Cardiovasc Med 2020; 7:97.
Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or nonischaemic heart disease: a systematic review and meta-analysis. Europace 2010; 12:1564–1570.
Merlo M, Cannatà A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail 2018; 20:228–239.
Cannatà A, Fabris E, Merlo M, et al. Sex differences in the long-term prognosis of dilated cardiomyopathy. Can J Cardiol 2020; 36:37–44.
Castrichini M, Porcari A, Baggio C, et al. Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis. ESC Heart Fail 2022; 9:4010–4019.
Fairweather D, Beetler DJ, Musigk N, et al. Sex and gender differences in myocarditis and dilated cardiomyopathy: an update. Front Cardiovasc Med 2023; 10:1129348.
Akdis D, Saguner AM, Shah K, et al. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome. Eur Heart J 2017; 38:1498–1508.
Planavila A, Laguna JC, Vazquez-Carrera M. Nuclear factorkappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 2005; 280:17464–17471.
Cavasin MA, Tao ZY, Yu AL, Yang XP. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am J Physiol Heart Circ Physiol 2006; 290:H2043–H2050.
Long C, Liu X, Xiong Q, Su Y, Hong K. Sex differences in dilated cardiomyopathy prognosis. Int Heart J 2022; 63:36–42.
Argirò A, Ho C, Day SM, et al. Sex-related differences in genetic cardiomyopathies. J Am Heart Assoc 2022; 11:e024947.